Younossi ZM, Stepanova M, Lawitz EJ, Reddy KR, Wai-Sun Wong V, Mangia A, Muir AJ, Jacobson I, Djedjos CS, Gaggar A, Myers RP, Younossi I, Nader F, Racila A. Patients with nonalcoholic steatohepatitis experience severe impairment of health-related quality of life. Am J Gastroenterol. 2019;114(10):1636–41.

PubMed  Google Scholar 

Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547–55.

PubMed  Google Scholar 

Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, Hunt S. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2015;62(6):1723–30.

CAS  PubMed  Google Scholar 

Le MH, Yeo YH, Zou B, Barnet S, Henry L, Cheung R, Nguyen MH. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach. Clin Mol Hepatol. 2022;28(4):841–50.

PubMed  PubMed Central  Google Scholar 

Eslam M, Sanyal AJ, George J, International Consensus P. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–20141.

CAS  PubMed  Google Scholar 

Zheng KI, Fan JG, Shi JP, Wong VW, Eslam M, George J, Zheng MH. From NAFLD to MAFLD: a “redefining” moment for fatty liver disease. Chin Med J (Engl). 2020;133(19):2271–3.

PubMed  Google Scholar 

Ramandi A, George J, Merat S, Jafari E, Sharafkhah M, Radmard AR, Nateghi Baygi A, Delavari A, Mohammadi Z, Poustchi H, Malekzadeh R. Polypill protects MAFLD patients from cardiovascular events and mortality: a prospective trial. Hepatol Int. 2023;17(4):882–8.

PubMed  Google Scholar 

Hoofnagle JH, Doo E. Letter to the editor: a multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2024;79(3):E91–2.

PubMed  Google Scholar 

Morvaridi M, Rayyani E, Jaafari M, Khiabani A, Rahimlou M. The effect of green coffee extract supplementation on cardio metabolic risk factors: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord. 2020;19(1):645–60.

CAS  PubMed  PubMed Central  Google Scholar 

Keshavarz Z, Rahimlou M, Farjam M, Homayounfar R, Khodadost M, Abdollahi A, Tabrizi R. Non-alcoholic fatty liver disease and dairy products consumption: results from FASA Persian cohort study. Front Nutr. 2022;9: 962834.

PubMed  PubMed Central  Google Scholar 

Simancas-Racines D, Annunziata G, Verde L, Fasci-Spurio F, Reytor-Gonzalez C, Muscogiuri G, Frias-Toral E, Barrea L. Nutritional strategies for battling obesity-linked liver disease: the role of medical nutritional therapy in metabolic dysfunction-associated steatotic liver disease (MASLD) management. Curr Obes Rep. 2025;14(1):7.

PubMed  PubMed Central  Google Scholar 

Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71.

CAS  PubMed  Google Scholar 

Song Q, Zhang X. The role of gut-liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC. Biomedicines. 2022;10(3).

Querio G, Antoniotti S, Geddo F, Levi R, Gallo MP. Modulation of endothelial function by TMAO, a gut microbiota-derived metabolite. Int J Mol Sci. 2023;24(6).

Nesci A, Carnuccio C, Ruggieri V, D'Alessandro A, Di Giorgio A, Santoro L, Gasbarrini A, Santoliquido A, Ponziani FR. Gut microbiota and cardiovascular disease: evidence on the metabolic and inflammatory background of a complex relationship. Int J Mol Sci. 2023;24(10).

Ramandi A, Diehl AM, Sanyal AJ, de Jong YP. Experimental Models to Investigate PNPLA3 in Liver Steatosis. Liver Int. 2025;45(5): e70091.

CAS  PubMed  PubMed Central  Google Scholar 

Yki-Jarvinen H, Luukkonen PK, Hodson L, Moore JB. Dietary carbohydrates and fats in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2021;18(11):770–86.

CAS  PubMed  Google Scholar 

Yki-Jarvinen H, Luukkonen PK. Diabetes, liver cancer, and cirrhosis: what next? Hepatology. 2018;68(4):1220–2.

PubMed  Google Scholar 

Luukkonen PK, Sadevirta S, Zhou Y, Kayser B, Ali A, Ahonen L, Lallukka S, Pelloux V, Gaggini M, Jian C, Hakkarainen A, Lundbom N, Gylling H, Salonen A, Oresic M, Hyotylainen T, Orho-Melander M, Rissanen A, Gastaldelli A, Clement K, Hodson L, Yki-Jarvinen H. Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care. 2018;41(8):1732–9.

CAS  PubMed  PubMed Central  Google Scholar 

Maskarinec G, Hullar MAJ, Monroe KR, Shepherd JA, Hunt J, Randolph TW, Wilkens LR, Boushey CJ, Le Marchand L, Lim U, Lampe JW. Fecal microbial diversity and structure are associated with diet quality in the multiethnic cohort adiposity phenotype study. J Nutr. 2019;149(9):1575–84.

PubMed  PubMed Central  Google Scholar 

Bowyer RCE, Jackson MA, Pallister T, Skinner J, Spector TD, Welch AA, Steves CJ. Use of dietary indices to control for diet in human gut microbiota studies. Microbiome. 2018;6(1):77.

PubMed  PubMed Central  Google Scholar 

Cotillard A, Cartier-Meheust A, Litwin NS, Chaumont S, Saccareau M, Lejzerowicz F, Tap J, Koutnikova H, Lopez DG, McDonald D, Song SJ, Knight R, Derrien M, Veiga P. A posteriori dietary patterns better explain variations of the gut microbiome than individual markers in the American Gut Project. Am J Clin Nutr. 2022;115(2):432–43.

PubMed  Google Scholar 

Kase BE, Liese AD, Zhang J, Murphy EA, Zhao L, Steck SE. The development and evaluation of a literature-based dietary index for gut microbiota. Nutrients. 2024;16(7).

Asnicar F, Berry SE, Valdes AM, Nguyen LH, Piccinno G, Drew DA, Leeming E, Gibson R, Le Roy C, Khatib HA, Francis L, Mazidi M, Mompeo O, Valles-Colomer M, Tett A, Beghini F, Dubois L, Bazzani D, Thomas AM, Mirzayi C, Khleborodova A, Oh S, Hine R, Bonnett C, Capdevila J, Danzanvilliers S, Giordano F, Geistlinger L, Waldron L, Davies R, Hadjigeorgiou G, Wolf J, Ordovas JM, Gardner C, Franks PW, Chan AT, Huttenhower C, Spector TD, Segata N. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med. 2021;27(2):321–32.

CAS  PubMed  PubMed Central  Google Scholar 

Parida S, Sharma D. Microbial alterations and risk factors of breast cancer: connections and mechanistic insights. Cells. 2020;9(5).

Zitvogel L, Galluzzi L, Viaud S, Vetizou M, Daillere R, Merad M, Kroemer G. Cancer and the gut microbiota: an unexpected link. Sci Transl Med. 2015;7(271):271.

Google Scholar 

An S, Qin J, Gong X, Li S, Ding H, Zhao X, He H, Zhou L, Deng X, Chu X. The mediating role of body mass index in the association between dietary index for gut microbiota and biological age: a study based on NHANES 2007–2018. Nutrients. 2024;16(23).

Zhang X, Yang Q, Huang J, Lin H, Luo N, Tang H. Association of the newly proposed dietary index for gut microbiota and depression: the mediation effect of phenotypic age and body mass index. Eur Arch Psychiatry Clin Neurosci. 2024.;

Albillos A, de Gottardi A, Rescigno M. The gut–liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72(3):558–77.

CAS  PubMed  Google Scholar 

Al Khodor S, Reichert B, Shatat IF. The microbiome and blood pressure: can microbes regulate our blood pressure? Front Pediatr. 2017;5:138.

PubMed  PubMed Central  Google Scholar 

Lee JH, Lee HS, Ahn SB, Kwon YJ. Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease. Clin Nutr. 2021;40(10):5252–60.

CAS  PubMed  Google Scholar 

Nestel PJ, Mori TA. Dairy foods: beneficial effects of fermented products on cardiometabolic health. Curr Nutr Rep. 2023;12(3):478–85.

PubMed  Google Scholar 

Musolino V, Cardamone A, Mare R, Coppoletta AR, Lorenzo F, Noto FR, Galluccio A, Tucci L, Lupia C, Carresi C, Marrelli M, Maurotti S, Gliozzi M, Montalcini T, Pujia A, Mollace V. Antioxidant and in vitro hepatoprotective activities of a polyphenol-rich fraction from the peel of citrus lumia risso (Rutaceae). Plants (Basel). 2025;14(8).

Pushpass RAG, Alzoufairi S, Jackson KG, Lovegrove JA. Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods. Nutr Res Rev. 2022;35(2):161–80.

CAS  PubMed  Google Scholar 

National Health and Nutrition Examination Survey. https://www.cdc.gov/nchs/nhanes.htm.

NCHS research ethics review (ERB) approval. https://www.cdc.gov/nchs/nhanes/irba98.htm.

Tacad DKM, Borkowski K, Keim NL. Differential associations of eating behavior traits, food preference, motivations of food choice on diet intake and diet quality in adult females and males from the USDA nutritional phenotyping study. Appetite. 2025;213: 108048.

PubMed  Google Scholar 

Mogna-Pelaez P, Riezu-Boj JI, Milagro FI, Clemente-Larramendi I, Esteban Echeverria S, Herrero JI, Elorz M, Benito-Boillos A, Tobaruela-Resola AL, Gonzalez-Muniesa P, Tur JA, Martinez JA, Abete I, Zulet MA. Sex-dependent gut microbiota features and functional signatures in metabolic disfunction-associated steatotic liver disease. Nutrients. 2024;16(23).

Park J, Kim G, Kim BS, Han KD, Kwon SY, Park SH, Lee YB, Jin SM, Kim JH. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2022;21(1):53.

PubMed  PubMed Central  Google Scholar 

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.

PubMed  PubMed Central  Google Scholar 

Han Y, Tang J, Wu N, Li Z, Ren H, Hu P, Chen Z. Association between the Life’s essential 8 health behaviors score and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease. Metabolism. 2024;163:156096.

PubMed  Google Scholar 

Mari L, Lazzer S, Gatti A, D'Alleva M, Zaccaron S, Stafuzza J, Rejc E, Vandoni M, Bondesan A, Caroli D, Frigerio F, Abbruzzese L, Ventura E, Sartorio A. Visceral adiposity, anthropometric and liver function indexes for identifying metabolic dysfunction associated steatotic liver disease (MASLD) in adolescents with obesity: which performs better? J Clin Med. 2025;14(6).

Li W, Wu H, Xu X, Zhang Y. Environmental exposure to perchlorate, nitrate, and thiocyanate in relation to chronic kidney disease in the general US population, NHANES 2005–2016. Chin Med J (Engl). 2023;136(13):1573–82.

CAS  PubMed  Google Scholar 

Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.

CAS  PubMed  PubMed Central  Google Scholar 

Allen AM, Therneau TM, Larson JJ, Coward A, Somers VK, Kamath PS. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study. Hepatology. 2018;67(5):1726–36.

CAS  PubMed